Coexpression Patterns of CD79a+TdT+ Precursors
| . | Mean % (range; n = 9) of CD79a+TdT+ Cells Positive With Marker . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CD19 . | CD34* . | CD10 . | CD10lo . | CD10hi . | CD33 . | CD7 . | MPO* . | cytoCD3* . | CD14* . | Control . | |
| Total | 78 (61-92) | 93 (88-97) | 96 (93-99) | 26 (17-33) | 73 (67-83) | 5 (1-8) | 6 (2-10) | 3 (2-6) | 3 (1-6) | 3 (1-8) | 2 (1-4) |
| CD19+ | ND | ND | 14 (7-17) | 87 (83-93) | 3 (1-4) | 4 (2-6) | 3 (2-5) | 3 (1-4) | 2 (1-6) | 2 (1-3) | |
| CD19− | ND | ND | 61 (30-79) | 39 (21-70) | 18 (2-29) | 17 (5-37) | 6 (3-12) | 5 (2-14) | 5 (2-13) | 4 (1-8) | |
| . | Mean % (range; n = 9) of CD79a+TdT+ Cells Positive With Marker . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CD19 . | CD34* . | CD10 . | CD10lo . | CD10hi . | CD33 . | CD7 . | MPO* . | cytoCD3* . | CD14* . | Control . | |
| Total | 78 (61-92) | 93 (88-97) | 96 (93-99) | 26 (17-33) | 73 (67-83) | 5 (1-8) | 6 (2-10) | 3 (2-6) | 3 (1-6) | 3 (1-8) | 2 (1-4) |
| CD19+ | ND | ND | 14 (7-17) | 87 (83-93) | 3 (1-4) | 4 (2-6) | 3 (2-5) | 3 (1-4) | 2 (1-6) | 2 (1-3) | |
| CD19− | ND | ND | 61 (30-79) | 39 (21-70) | 18 (2-29) | 17 (5-37) | 6 (3-12) | 5 (2-14) | 5 (2-13) | 4 (1-8) | |
Values were derived from gating experiments as described in Materials and Methods.
Abbreviations: n, number of investigated normal samples; ND, not determined.
n = 5 investigated samples.